In 2010, Brazil introduced the 10-valent pneumococcal conjugate vaccine (PCV10) into the national children’s immunization programme. This study describes the genetic characteristics of invasive Streptococcus pneumoniae isolates before and after PCV10 introduction. A subset of 466 [pre-PCV10 (2008–2009): n=232, post-PCV10 (2012–2013): n=234;<5 years old: n=310, ≥5 years old: n=156] pneumococcal isolates, collected through national laboratory surveillance, were whole-genome sequenced (WGS) to determine serotype, pilus locus, antimicrobial resistance and genetic lineages. Following PCV10 introduction, in the <5 years age group, non-vaccine serotypes (NVT) serotype 3 and serotype 19A were the most frequent, and serotypes 12F, 8 and 9 N in the ≥5 years old group. The study identified 65 Global Pneumococcal Sequence Clusters (GPSCs): 49 (88 %) were GPSCs previously described and 16 (12 %) were Brazilian clusters. In total, 36 GPSCs (55 %) were NVT lineages, 18 (28 %) vaccine serotypes (VT) and 11 (17 %) were both VT and NVT lineages. In both sampling periods, the most frequent lineage was GPSC6 (CC156, serotypes 14/9V). In the <5 years old group, a decrease in penicillin (P=0.0123) and cotrimoxazole (P<0.0001) resistance and an increase in tetracycline (P=0.019) were observed. Penicillin nonsusceptibility was predicted in 40 % of the isolates; 127 PBP combinations were identified (51 predicted MIC≥0.125 mg l−1); cotrimoxazole (folA and/or folP alterations), macrolide (mef and/or ermB) and tetracycline (tetM, tetO or tetS/M) resistance were predicted in 63, 13 and 21.6 % of pneumococci studied, respectively. The main lineages associated with multidrug resistance in the post-PCV10 period were composed of NVT, GPSC1 (CC320, serotype 19A), and GPSC47 (ST386, serotype 6C). The study provides a baseline for future comparisons and identified important NVT lineages in the post-PCV10 period in Brazil.
BrandileoneMC, AlmeidaSCG, BokermannS, MinamisavaR, BerezinEN et al. Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019. Vaccine2021; 39:3207–3215 [View Article]
ChaguzaC, CornickJE, AndamCP, GladstoneRA, AlaertsM et al. Population genetic structure, antibiotic resistance, capsule switching, and evolution of invasive pneumococci before conjugate vaccination in Malawi. Vaccine2017; 35:4594–4602 [View Article]
ChaguzaC, HeinsbroekE, GladstoneRA, TafatathaT, AlaertsM et al. Early signals of vaccine-driven perturbation seen in pneumococcal carriage population genomic data. Clin Infect Dis2020; 70:1294–1303 [View Article]
BrandileoneMCC, AlmeidaSCG, MinamisavaR, AndradeAL. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of a 10-valent pneumococcal conjugate vaccine in Brazil. Vaccine2018; 36:2559–2566 [View Article]
WHO Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae; 2011https://apps.who.int/iris/handle/10665/70765
Clinical and Laboratory Standards Institute (CLSI)Performance Standards for Antimicrobial Disk Susceptibility Tests, 13th edn. Wayne, PA: Clinical and Laboratory Standard Institute; 2018
Clinical and Laboratory Standards Institute (CLSI)Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 11th edn. Wayne, PA: Clinical and Laboratory Standard Institute; 2018
Clinical and Laboratory Standards Institute (CLSI)Performance Standards for Antimicrobial Susceptibility Testing, 29th edn. Wayne, PA: Clinical and Laboratory Standard Institute; 2019
GladstoneRA, LoSW, LeesJA, CroucherNJ, van TonderAJ et al. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine2019; 43:338–346 [View Article]
MetcalfBJ, GertzREJr, GladstoneRA, WalkerH, SherwoodLK et al. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect2016; 22:60 [View Article]
LeesJA, HarrisSR, Tonkin-HillG, GladstoneRA, LoSW et al. Fast and flexible bacterial genomic epidemiology with PopPUNK. Genome Res2019; 29:304–316 [View Article]
GladstoneRA, LoSW, GoaterR, YeatsC, TaylorB et al. Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genomics2020; 6:1–13 [View Article]
LiY, MetcalfBJ, ChochuaS, LiZ, GertzRE et al. Penicillin-binding protein transpeptidase signatures for tracking and predicting-lactam resistance levels in Streptococcus pneumoniae. mBio2016; 7:1–9 [View Article]
MagiorakosAP, SrinivasanA, CareyRB, CarmeliY, FalagasME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect2012; 18:268–281 [View Article]
AndradeAL, MinamisavaR, PolicenaG, CristoEB, DominguesCMS et al. Evaluating the impact of PCV-10 on the invasive pneumococcal disease in Brazil: A time-series analysis. Hum Vaccines Immunother2016; 12:285–292 [View Article]
PintoTCA, NevesFPG, SouzaARV, OliveiraLMA, CostaNS et al. Evolution of penicillin non-susceptibility among Streptococcus pneumoniae isolates recovered from asymptomatic carriage and invasive disease over 25 years in Brazil, 1990-2014. Front Microbiol2019; 10:486 [View Article]
AlmeidaSCG, HawkinsPA, CassiolatoAP, DiasUJ, GladstoneRA et al.Molecular characterization of Streptococcus pneumoniae strains isolated from the invasive disease in the pre- and post-PCV10 periods in Brazil, 2005 to 2015. 11th International Symposium on Pneumococci & Pneumococcal Diseases, April 15-19, 2018 Melbourne, Australia: 2018
KimL, McgeeL, TomczykS, BeallBW. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: A United States perspective. Clin Microbiol Rev2016; 29:525–552 [View Article]
dos SantosMS, AzevedoJ, de Oliveria MenezesAP, CordeiroSM, EscobarEC et al. Temporal trends and clonal diversity of penicillin non-susceptible pneumococci from meningitis cases from 1996 to 2012, in Salvador, Brazil. BMC Infect Dis2015; 15:1–10 [View Article]
CaierãoJ, HawkinsP, Sant’annaFH, da CunhaGR, D’AzevedoPA et al. Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil. PLoS One2014; 9:1–20 [View Article]
BrandileoneMCC, ZanellaRC, AlmeidaSCG, CassiolatoAP, LemosAPS et al. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil. Vaccine2019; 37:5357–5363 [View Article]
AlmeidaSCG, CassiolatoAP, DiasUJ, GuerraMLL e S, PradoLS do et al.Molecular characterization of invasive Streptococcus pneumoniae isolated in Pre (2005-2009) and Post (2011-2015) 10-valent pneumococcal conjugate vaccine introduction in Brazil. 37th Annual Meeting of the European Society for Paediatric Infectious Diseases, May 5 – 11, 2019 Ljubljana, Slovenia: 2019abstracts (ESPID19-0518):1164https://2019.espidmeeting.org/espid-abstracts/
LoSW, GladstoneRA, van TonderAJ, LeesJA, du PlessisM et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis2019; 3099:1–11 [View Article]
WoutersI, DesmetS, Van HeirstraetenL, BlaizotS, VerhaegenJ et al. Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium. Vaccine2019; 37:1080–1086 [View Article]
Rinta-KokkoH, PalmuAA, AuranenK, NuortiJP, ToropainenM et al. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland. Vaccine2018; 36:1934–1940 [View Article]
DesmetS, VerhaegenJ, Van RanstM, PeetermansW, LagrouK. Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?. Lancet Infect Dis2018; 18:830–831 [View Article]
PotinM, FicaA, WilhemJ, CerdaJ, ContrerasL et al. Opinión del Comité Consultivo de Inmunizaciones Sociedad Chilena de Infectología: vacuna neumocóccica conjugada en niños y la emergencia de serotipo 19A. Rev Chil Infectología2016; 33:304–306 [View Article]
MooreMR, GertzRE, WoodburyRL, Barkocy‐GallagherGA, SchaffnerW et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis2008; 197:1016–1027 [View Article]
ChenYY, WangJT, LinTL, GongYN, LiTH et al. Prophage excision in Streptococcus pneumoniae serotype 19A ST320 promote colonization: Insight into its evolution from the ancestral clone Taiwan 19F-14 (ST236. Front Microbiol2019; 10:1–10 [View Article]
MetcalfBJ, ChochuaS, GertzRE, LiZ, WalkerH et al. Using whole-genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for the year 2015 invasive pneumococcal disease isolates recovered in the United States. Clin Microbiol Infect2016; 22:e1-1002.e8 [View Article]
DaganR, Givon‐LaviN, LeibovitzE, GreenbergD, PoratN. Introduction and proliferation of multidrug‐resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis2009; 199:776–785 [View Article]
BeallB, GertzRE, HulkowerRL, WhitneyCG, MooreMR et al. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis2011; 203:1360–1368 [View Article]
ChoiEH, KimSH, EunBW, KimSJ, KimNH et al.Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis2008; 14:275–281 [View Article]
MottM, CaierãoJ, CunhaGR, Del MaschiMM, PizzutiK et al. Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with an ST320 in adult population, in Porto Alegre. Epidemiol Infect2019; 147:1–7 [View Article]
CassiolatoAP, AlmeidaSCG, AndradeAL, MinamisavaR, BrandileoneMCC. Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil. PLoS One2018; 13:1–13 [View Article]
ChristopheBL, MottM, da CunhaG, CaierãoJ, D’AzevedoPA et al. Characterisation of Streptococcus pneumoniae isolates from the invasive disease in adults following the introduction of PCV10 in Brazil. J Med Microbiol2018; 67:687–694 [View Article]
AzarianT, MitchellPK, GeorgievaM, ThompsonCM, GhouilaA et al. Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci. PLoS Pathog2018; 14:e1007438 [View Article]
SetchanovaL, AlexandrovaA, PenchevaD, SirakovI, MihovaK et al. Rise of multidrug-resistant Streptococcus pneumoniae clones expressing nonvaccine serotypes among children after introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria. J Glob Antimicrob Resist2018; 15:6–11 [View Article]
Del AmoE, EstevaC, Hernandez-BouS, GallesC, NavarroM et al. Serotypes and clonal diversity of Streptococcus pneumoniae causing invasive disease in the Era of PCV13 in Catalonia, Spain. PLoS One2016; 11:1–12 [View Article]
JolleyKA, BrayJE, MaidenMCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res2018; 24:124 [View Article]
NevesFPG, CardosoNT, SouzaAR, SnyderRE, MarlowMM et al. Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage. J Antimicrob Chemother2018; 73:1206–1212 [View Article]
PintoTCA, KegeleFCO, DiasCAG, BarrosRR, PeraltaJM et al.Streptococcus pneumoniae serotypes 9 and 14 circulating in Brazil over 23 years before the introduction of the 10-Valent pneumococcal conjugate vaccine: role of international clones in the evolution of antimicrobial resistance and description of a novel genotype. Antimicrob Agents Chemother2016; 60:6664–6672 [View Article]
CarvalhoMDG, PimentaFC, GertzRE, JoshiHH, TrujilloAA et al. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol2009; 47:554–559 [View Article]
LambertsenL, KerrnMB. Test of a novel Streptococcus pneumoniae serotype 6C type specific polyclonal antiserum (Factor Antiserum 6d) and characterisation of serotype 6C isolates in Denmark. BMC Infect Dis2010; 10: [View Article]
JanoirC, CohenR, LevyC, BingenE, LepoutreA et al. Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France. PLoS One2014; 9:1–11 [View Article]
CohenR, BiscardiS, LevyC. The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014. Hum Vaccin Immunother2016; 12:277–284 [View Article]
CornickJE, BentleySD. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones, and macrolides. Microbes Infect2012; 14:573–583 [View Article]
YildirimI, SheaKM, PeltonSI. Pneumococcal disease in the era of pneumococcal conjugate vaccine. Infect Dis Clin North Am2015; 29:679–697 [View Article]
DzaralyND, MuthannaAR, DesaNNM, TaibNM, MasriSN et al. Pilus islets and the clonal spread of piliated Streptococcus pneumoniae: A review. Int J Med Microbiol2020; 310:151499 [View Article]
ZemlickovaH, JakubuV, FridrichovaM, MalisovaL, MusilekM et al. The association of pili with the emergence and replacement of the major antibiotic resistant pneumococcal clones. J Microbiol Immunol Infect2020; 53:690–695 [View Article]
AguiarSI, SerranoI, PintoFR, Melo-CristinoJ, RamirezM. The presence of the pilus locus is a clonal property among pneumococcal invasive isolates. BMC Microbiol2008; 8:1–11 [View Article]
WahlB, O’BrienKL, GreenbaumA, MajumderA, LiuL et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Heal2018; 6:e744–57 [View Article]
MacIntyreCR, ChughtaiAA, BarnesM, RiddaI, SealeH et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza an (H1N1) pdm09. BMC Infect Dis2018; 18:1–20 [View Article]